- $6.73bn
- $6.28bn
- $22.29m
Brief: Arcellx Announces Upsizing And Pricing Of Follow-On Public Offering Of 7 Million Shares At A Price Of $16.00 Per Share
Brief: Arcellx Inc Raises Size Of Common Stock Offering To 5.0 Million Shares From 4.0 Million Shares
U.S. STOCKS ON THE MOVE-SeaChange International, Revlon, FedEx
U.S. STOCKS ON THE MOVE-Qudian Inc, Coda Octopus Group, Revlon Inc
Arcellx slides on stock offering
Brief: Arcellx Files For Offering Of Up To 4.0 Mln Shares Of Common Stock
Brief: Arcellx Presents Continued Robust Long-Term Responses From Its CART-DDBCMA Phase 1 Expansion Trial In Patients With Relapsed Or Refractory Multiple Myeloma
Brief: Arcellx Appoints Michelle Gilson As Chief Financial Officer
Brief: Arcellx Board Decreased Number Of Its Authorized Directors From Nine To Seven
Brief: Arcellx Appoints Olivia Ware To Board Of Directors
Brief: Arcellx Reports First Quarter 2022 Financial Results
Brief: Arcellx Doses First Patient In Phase 1 Trial Evaluating Treatment Of Relapsed Or Refractory Multiple Myeloma
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:35 AM
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:00 AM